Lorenzo Tallarigo, Director, 10% Owner at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1,123,415 shares at $62.50 ($70.2M) on 2013-10-15, disclosed to the SEC on 2013-10-17.
Open-market sale of $70.2M ICPT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2014-04-11 | $111.0M | — | Filing → |
| ICPT | SELL | 2014-02-11 | $130K | — | Filing → |
| ICPT | SELL | 2014-01-09 | $124K | — | Filing → |